These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 16271442)

  • 61. MR imaging of diverse manifestations of nasopharyngeal carcinomas.
    Chin SC; Fatterpekar G; Chen CY; Som PM
    AJR Am J Roentgenol; 2003 Jun; 180(6):1715-22. PubMed ID: 12760949
    [No Abstract]   [Full Text] [Related]  

  • 62. [2005 WHO histological classification of tumours of the nasopharynx and TNM classification of carcinoma].
    Wang SY; Zhu L; Li SM
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2007 Aug; 42(8):638-40. PubMed ID: 17944224
    [No Abstract]   [Full Text] [Related]  

  • 63. Volume determination of oral cavity tumors by 3-dimensional ultrasonography.
    Rebol J
    J Oral Maxillofac Surg; 2008 Nov; 66(11):2296-301. PubMed ID: 18940495
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Evaluation of Volume of Nasopharyngeal Cancers by the Cavalieri Principle.
    Tatar A; Ozmen HK; Yoruk O
    Asian Pac J Cancer Prev; 2018 Sep; 19(9):2403-2407. PubMed ID: 30255692
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma.
    Chen MK; Lee HS; Chang JH; Chang CC
    J Otolaryngol; 2004 Oct; 33(5):304-7. PubMed ID: 15931815
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Morphometric and stereologic nuclear values obtained from the study of a population suffering from nasopharyngeal carcinoma].
    Pérez Plasencia D; Flores Corral T; Urrutia Avisrror M; Santa Cruz Ruiz S; Benito González J; Mateos Pérez MM; Gómez González JL
    An Otorrinolaringol Ibero Am; 2002; 29(6):593-603. PubMed ID: 12596351
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Clinical classification of benign ENT tumor].
    Antoniv VF; Rishko NM; Popadiuk VI; Pronchenko SV
    Vestn Otorinolaringol; 2001; (4):24-7. PubMed ID: 11530473
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Efficiency of the TNM system of tumor classification. Epidemiologic studies].
    Baumann RP; Raymond L
    Fortschr Med; 1983 Apr; 101(16):730-4. PubMed ID: 6852746
    [No Abstract]   [Full Text] [Related]  

  • 69. [TNM staging and classification for malignant tumors: I. General considerations].
    Qiu WL
    Shanghai Kou Qiang Yi Xue; 1993 Jun; 2(2):121-2. PubMed ID: 15159868
    [No Abstract]   [Full Text] [Related]  

  • 70. [TNM classification].
    Ishikawa S
    Gan No Rinsho; 1967; 13(4):207. PubMed ID: 5624313
    [No Abstract]   [Full Text] [Related]  

  • 71. Pretreatment [
    Gihbid A; Cherkaoui Salhi G; El Alami I; Belgadir H; Tawfiq N; Bendahou K; El Mzibri M; Cadi R; El Benna N; Guensi A; Khyatti M
    Ann Nucl Med; 2022 Oct; 36(10):876-886. PubMed ID: 35836088
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The evolution of nasopharyngeal carcinoma staging.
    Guo R; Mao YP; Tang LL; Chen L; Sun Y; Ma J
    Br J Radiol; 2019 Oct; 92(1102):20190244. PubMed ID: 31298937
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Interplay of Tumor Spread, Volume and Epstein-Barr Virus DNA in Nasopharyngeal Carcinoma: Feasibility of An Integrative Risk Stratification Scheme.
    Zhou X; Yang Y; Ou X; Xu T; Shen C; Hu C
    J Cancer; 2018; 9(22):4271-4278. PubMed ID: 30519329
    [No Abstract]   [Full Text] [Related]  

  • 74. Unidimensional measurement may be superior to assess primary tumor response after neoadjuvant chemotherapy for nasopharyngeal carcinoma.
    Chen C; Lin X; Xu Y; Bai P; Xiao Y; Pan Y; Li C; Lin Z; Zhang M; Chen Y
    Oncotarget; 2017 Jul; 8(29):46937-46945. PubMed ID: 28159937
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tumour volumes: Predictors of early treatment response in locally advanced head and neck cancers treated with definitive chemoradiation.
    Ahlawat P; Rawat S; Kakria A; Pal M; Chauhan D; Tandon S; Jain S
    Rep Pract Oncol Radiother; 2016; 21(5):419-26. PubMed ID: 27489511
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Is maximum primary tumor diameter still a prognostic factor in patients with nasopharyngeal carcinoma treated using intensity-modulated radiotherapy?
    Chen Y; Hu XF; Wang Y; Chen HY; Yang L; Liu LZ; Cui CY; Liu DS; Liang SB
    BMC Cancer; 2015 Apr; 15():305. PubMed ID: 25903652
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.
    Choi KH; Yoo IeR; Han EJ; Kim YS; Kim GW; Na SJ; Sun DI; Jung SL; Jung CK; Kim MS; Lee SY; Kim SH
    Nucl Med Mol Imaging; 2011 Mar; 45(1):43-51. PubMed ID: 24899977
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary tumor regression speed after radiotherapy and its prognostic significance in nasopharyngeal carcinoma: a retrospective study.
    Zhang N; Liang SB; Deng YM; Lu RL; Chen HY; Zhao H; Lv ZQ; Liang SQ; Yang L; Liu DS; Chen Y
    BMC Cancer; 2014 Feb; 14():136. PubMed ID: 24571531
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic significance of maximum primary tumor diameter in nasopharyngeal carcinoma.
    Liang SB; Deng YM; Zhang N; Lu RL; Zhao H; Chen HY; Li SE; Liu DS; Chen Y
    BMC Cancer; 2013 May; 13():260. PubMed ID: 23710879
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Correlation between nasopharyngeal carcinoma tumor volume and the 2002 International Union Against Cancer tumor classification system.
    Wu Z; Gu MF; Zeng RF; Su Y; Huang SM
    Radiat Oncol; 2013 Apr; 8():87. PubMed ID: 23578324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.